Established in 1998 and located in Taipei, Taiwan, Simpson Biotech Co., Ltd. focuses on the development and commercialization of bio-fermentation of medicinal fungus as dietary supplements and the isolation of active compounds from the fungal mycelia. Simpson Biotech has developed a patented platform technology for recombinant proteins expression and purification for biosimilars and industrial enzymes.SBC has developed a cost-effective platform technology that significantly reduces the production costs of recombinant proteins, biologics, and industrial enzymes by improving their purification processes.
Simpson Biotech Co., Ltd has significant expertise in microbial and enzymatic processes for value-added agriculture, food, health, and industrial applications. Simpson Biotech's capabilities span a wide range of health and industrial applications and leverage a high-volume fermentation facility. Simpson Biotech has won numerous awards including the Taipei Biotech Award from Taipei city government and the National Innovation Award from the Institute for Biotechnology and Medicine in Taiwan. SBC holds 14 issued patents with another 56 pending.
Simpson Biotech is known for its portfolio of patents and intellectual property in the fermentation of medicinal mycelia. In addition Simpson Biotech has significant expertise in enzymatic processing and microbial strain selection and control. Together with modern capabilities in recombinant protein development Simpson Biotech brings a strong technology platform to assist with process development, the licensing of its technology platform, or the supply of bulk and consumer grade materials.